Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
RANTIN
BRANDED
Ranitidine is a reversible competitive antagonist for histamine receptors in the parietal cells of the gastric mucosa, therefore ranitidine effectively inhibits gastric acid secretion.
Available at :
Share this article
Related
Articles
.
by dr. Dita Arccinirmala | 04 Jun 2025
COVID-19 Cases Increased in Several Countries, Is COVID-19 Booster Vaccine Required?
by dr. Dita Arccinirmala | 26 May 2025
Tripledemic Alert, 3 Concurrent Respiratory Infections
by dr. Dita Arccinirmala | 20 May 2025
Serplulimab Approved for First-line Treatment of Extensive Stage Small Cell Lung Cancer (ES-SCLC) in the European Union
by dr. Dita Arccinirmala | 06 Feb 2025
Virus that causes COVID-19 variant JN.1 detected in Indonesia, Stay Alert!
by dr. Vivian Keung | 21 Dec 2023
Tocilizumab Effectively Reduces Mortality of Hospitalized COVID-19 Patients; It's a Meta-Analysis Study
by dr. Nugroho Nitiyoso, MBA | 02 Aug 2022
Baricitinib Beneficial in Reducing Mortality of Hospitalized COVID-19 Patients
by dr. Nugroho Nitiyoso, MBA | 29 Jun 2022
New Omicron BA.4 and BA.5 Subvariants Detected in Indonesia, Here's What You Need to Know
by dr. Dita Arccinirmala | 14 Jun 2022
ASCO Recommendations Regarding Diet and Exercise for Cancer Patients
by Dr. Dedyanto Henky Saputro, M. Gizi, AIFO-K | 17 Jun 2022
TPC Induction Chemotherapy for Advanced Locoregional Nasopharyngeal Cancer Patients
by dr. Hastarita Lawrenti | 12 Apr 2022
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE